Baker Tilly Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
9,954
-192
-2% -$44.7K 0.54% 41
2026
Q1
$2.48M Sell
10,146
-63
-0.6% -$14.7K 0.6% 37
2025
Q4
$2.11M Buy
10,209
+1,010
+11% +$200K 0.52% 41
2025
Q3
$1.71M Buy
9,199
+1,377
+18% +$236K 0.39% 50
2025
Q2
$1.19M Sell
7,822
-182
-2% -$28K 0.43% 43
2025
Q1
$1.33M Buy
8,004
+2,221
+38% +$348K 0.52% 36
2024
Q4
$836K Sell
5,783
-647
-10% -$100K 0.33% 72
2024
Q3
$1.04M Sell
6,430
-1,725
-21% -$275K 0.46% 51
2024
Q2
$1.19M Sell
8,155
-11,747
-59% -$1.75M 0.49% 37
2024
Q1
$3.15M Sell
19,902
-2,578
-11% -$410K 0.57% 34
2023
Q4
$3.52M Sell
22,480
-3,314
-13% -$508K 0.58% 31
2023
Q3
$4.02M Sell
25,794
-13,284
-34% -$2.19M 0.66% 27
2023
Q2
$6.47M Sell
39,078
-568
-1% -$91.7K 0.68% 29
2023
Q1
$6.15M Buy
39,646
+1,268
+3% +$205K 0.69% 26
2022
Q4
$6.78M Buy
38,378
+3,978
+12% +$687K 0.83% 16
2022
Q3
$5.62M Sell
34,400
-767
-2% -$130K 0.77% 22
2022
Q2
$6.24M Buy
35,167
+368
+1% +$65.6K 0.82% 18
2022
Q1
$6.17M Buy
34,799
+390
+1% +$66.4K 0.68% 28
2021
Q4
$5.89M Buy
34,409
+3,613
+12% +$591K 0.63% 32
2021
Q3
$4.97M Buy
30,796
+3,668
+14% +$626K 0.66% 24
2021
Q2
$4.47M Buy
27,128
+1,048
+4% +$174K 0.72% 20
2021
Q1
$4.29M Buy
26,080
+7,001
+37% +$1.13M 0.88% 14
2020
Q4
$3M Buy
+19,079
New +$2.82M 0.93% 18

Other funds holding JNJ

Baker Tilly Wealth Management's JNJ Position: Q2 2026 in Review

Baker Tilly Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, selling an estimated $44.7K and leaving 9,954 shares worth $2.53M. The position accounts for 0.54% of the portfolio, ranked #41.

Baker Tilly Wealth Management first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.78M in Q4 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Baker Tilly Wealth Management held 9,954 shares of Johnson & Johnson worth $2.53M as of Q2 2026.
  • Baker Tilly Wealth Management sold 192 Johnson & Johnson shares in Q2 2026, an estimated $44.7K.
  • Johnson & Johnson made up 0.54% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Baker Tilly Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • Baker Tilly Wealth Management's Johnson & Johnson position peaked at $6.78M in Q4 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.